Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway
Lan Zhan, Xiangxiu Wang, Yanjing Zhang, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 11

Showing 11 citing articles:

A Look at the Importance of Chirality in Drug Activity: Some Significative Examples
Jessica Ceramella, Domenico Iacopetta, Angelica Franchini, et al.
Applied Sciences (2022) Vol. 12, Iss. 21, pp. 10909-10909
Open Access | Times Cited: 74
Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
Ye Chen‐Izu, Saixian Shi, Yan Dai
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113903-113903
Open Access | Times Cited: 69
Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1553-1553
Open Access | Times Cited: 66
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways
Ziyun Lu, Zhiyi Liu, Bei Fang
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9145-9155
Open Access | Times Cited: 24
A Facile Way to Enhance the Therapeutic Efficacy of Hydrophobic Drugs via Amorphous Solid Dispersions
Tao Ning, Zhaoxiong Yan, Xin Wang, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Closed Access
PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K/AKT phosphorylation
Yaling Yin, Qianqian Niu, Hongyan Hou, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109274-109274
Closed Access | Times Cited: 14
Differences in Levels of Mitochondrial DNA Content at Various Stages of Canine Myxomatous Mitral Valve Disease
Suphakan Chirathanaphirom, Phongsakorn Chuammitri, Wanpitak Pongkan, et al.
Animals (2023) Vol. 13, Iss. 24, pp. 3850-3850
Open Access | Times Cited: 4
Analysis and Validation of Differentially Expressed Ferroptosis-Related Genes in Regorafenib-Induced Cardiotoxicity
Siyuan Zhang, Xueming Xu, Zhangyi Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 4
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Ziyu Kuang, Yuansha Ge, Luchang Cao, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1038-1054
Open Access
Mechanism of PI3K/Akt‑mediated mitochondrial pathway in obesity‑induced apoptosis (Review)
Jiarui Li, Manyi Sun, Ming Tang, et al.
Biomedical Reports (2024) Vol. 22, Iss. 3
Open Access
Page 1

Scroll to top